MDCX (STOCKS)
Medicus Pharma Ltd. Common Stock
$0.415000
+0.001000 (+0.24%)
Prev close: $0.414000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Raza Bokhari
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16.00M
- Employees
- 12
- P/E (TTM)
- -0.22
- P/B (TTM)
- -205.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | -$197.38K |
| Benefits Costs and Expenses | $35.25M |
| Costs And Expenses | $35.25M |
| Operating Expenses | $34.36M |
| Research and Development | $7.72M |
| Other Operating Expenses | $26.64M |
| Operating Income/Loss | -$34.36M |
| Income/Loss From Continuing Operations After Tax | -$35.44M |
| Income/Loss From Continuing Operations Before Tax | -$35.44M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Interest Income/Expense After Provision For Losses | -$197.38K |
| Interest Income/Expense Operating, Net | -$197.38K |
| Net Income/Loss | -$35.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$146.00 |
| Net Income/Loss Attributable To Parent | -$47.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$47.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $146.00 |
| Preferred Stock Dividends And Other Adjustments | $146.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$2.74 |
| Diluted Earnings Per Share | -$2.74 |
| Basic Average Shares | 17,283,824 |
| Diluted Average Shares | 17,283,824 |
| Assets | $10.06M |
| Current Assets | $9.89M |
| Prepaid Expenses | $1.09M |
| Other Current Assets | $8.80M |
| Noncurrent Assets | $170.73K |
| Liabilities | $10.02M |
| Current Liabilities | $9.94M |
| Accounts Payable | $3.44M |
| Wages | $300.18K |
| Other Current Liabilities | $6.20M |
| Noncurrent Liabilities | $86.00K |
| Equity | $37.31K |
| Equity Attributable To Noncontrolling Interest | $104.87K |
| Equity Attributable To Parent | -$67.55K |
| Liabilities And Equity | $10.06M |
| Net Cash Flow From Operating Activities | -$22.78M |
| Net Cash Flow From Operating Activities, Continuing | -$22.78M |
| Net Cash Flow From Investing Activities | -$4.62M |
| Net Cash Flow From Investing Activities, Continuing | -$4.62M |
| Net Cash Flow From Financing Activities | $31.94M |
| Net Cash Flow From Financing Activities, Continuing | $31.94M |
| Exchange Gains/Losses | -$2.97K |
| Net Cash Flow | $4.54M |
| Net Cash Flow, Continuing | $4.54M |
| Comprehensive Income/Loss | -$47.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$150.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.29M |
| Other Comprehensive Income/Loss | -$11.85M |